内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Simon Amy. Officer active across 1 company, notably Beam Therapeutics Inc.. Cumulatively, 15 reports have been recorded. Split: 0 buy · 10 sells. Total volume traded: €1.1m. History available since 31 March 2023. The latest transaction was filed on 27 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Simon Amy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
16,667 股@ US$25.7417Common StockSEC:0001193125-26-323640:0
373 股Common StockSEC:0001193125-26-294478:0
6,700 股@ US$24.5819.6% 占其流量Common StockSEC:0001193125-26-144080:0
31,750 股0Common StockSEC:0001193125-26-140515:0
12,500 股0Common StockSEC:0001193125-26-002422:0
374 股@ US$16.94230.7% 占其流量Common StockSEC:0000950170-25-094002:0
9,566 股@ US$18.350627.9% 占其流量Common StockSEC:0000950170-25-050852:0
27,500 股0Common StockSEC:0000950170-25-049765:0
502 股@ US$23.761.9% 占其流量Common StockSEC:0000950170-24-081492:0
7,157 股@ US$32.1336.7% 占其流量Common StockSEC:0000950170-24-041441:0
27,500 股0Common StockSEC:0000950170-24-040152:0
3,448 股@ US$18.7010.5% 占其流量Common StockSEC:0000950170-23-057499:0
391 股@ US$30.481.9% 占其流量Common StockSEC:0000950170-23-040574:0
4,445 股@ US$30.3121.2% 占其流量Common StockSEC:0000899243-23-010816:0
20,000 股0Common StockSEC:0000899243-23-010134:0
About Simon Amy
Simon Amy is Chief Medical Officer at Beam Therapeutics Inc. (XNAS). Across 10 filings recorded, the 10 sampled filings, all sales, cover the period from 2023-03-31 to 2026-07-02 and total 583211 EUR in sell transactions, with no purchases reported.